Education
About Us
Working with TipRanks
Follow Us
Modern Healthcare Technology Holdings Limited (DE:M3L)
FRANKFURT:M3L
M3L Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume0.00
Average Volume (3M)N/A
Market Cap
€9.01M
Enterprise Value-$137.27M
Total Cash (Recent Filing)€301.73M
Total Debt (Recent Filing)€62.90M
Price to Earnings (P/E)2.6
Beta9.21
Next Earnings
Jul 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding904,483,950
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)0.36
Price to Sales (P/S)0.15
P/FCF Ratio0.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved LeverageImproved debt-to-equity signals sustainably lower financial risk and greater balance sheet flexibility. Over the next 2–6 months this reduces interest burden and refinancing pressure, enabling the company to allocate cash to operations or strategic investments rather than urgent deleveraging.
Strong Free Cash Flow GrowthConsistent free cash flow growth supports durable operational funding and strategic optionality. Reliable cash conversion cushions the business against sustained operating losses, funds working capital, and can finance capex or debt paydown over multiple quarters without relying on equity raises.
Healthy Gross Margins / Stable Equity RatioSustained gross margins indicate fundamental product or pricing strength that can underpin recovery once fixed-cost pressures ease. A stable equity ratio reflects a resilient asset base to support operations and fundraising, preserving capacity to invest or restructure over the medium term.
Bears Say
Declining Revenue GrowthA shrinking top line erodes operating leverage and makes fixed costs a larger drag on profitability. Persistent revenue decline over several quarters risks market share loss, reduced scale benefits, and forces margin trade-offs that can hamper recovery and investment capacity over months.
Negative Net Margins And ROENegative net margins and ROE show the company is not converting sales into shareholder returns, draining equity value. Over a multi-quarter horizon this limits reinvestment, weakens ability to self-fund growth, and increases reliance on cash reserves or external financing.
Declining EBIT/EBITDA MarginsFalling EBIT and EBITDA margins point to deteriorating core operating efficiency; this reduces free cash generation and resilience to shocks. Unless addressed, margin erosion will persistently pressure cash flows, constrain strategic investments, and may necessitate restructuring to restore competitiveness.
Modern Healthcare Technology Holdings Limited News
M3L FAQ
What was Modern Healthcare Technology Holdings Limited’s price range in the past 12 months?
Currently, no data Available
What is Modern Healthcare Technology Holdings Limited’s market cap?
Modern Healthcare Technology Holdings Limited’s market cap is €9.01M.
When is Modern Healthcare Technology Holdings Limited’s upcoming earnings report date?
Modern Healthcare Technology Holdings Limited’s upcoming earnings report date is Jul 01, 2026 which is in 104 days.
How were Modern Healthcare Technology Holdings Limited’s earnings last quarter?
Modern Healthcare Technology Holdings Limited released its earnings results on Nov 28, 2025. The company reported <$0.001 earnings per share for the quarter, beating the consensus estimate of N/A by <$0.001.
Is Modern Healthcare Technology Holdings Limited overvalued?
According to Wall Street analysts Modern Healthcare Technology Holdings Limited’s price is currently Overvalued.
Does Modern Healthcare Technology Holdings Limited pay dividends?
Modern Healthcare Technology Holdings Limited does not currently pay dividends.
What is Modern Healthcare Technology Holdings Limited’s EPS estimate?
Modern Healthcare Technology Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Modern Healthcare Technology Holdings Limited have?
Modern Healthcare Technology Holdings Limited has 904,483,950 shares outstanding.
What happened to Modern Healthcare Technology Holdings Limited’s price movement after its last earnings report?
Modern Healthcare Technology Holdings Limited reported an EPS of <$0.001 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Modern Healthcare Technology Holdings Limited?
Currently, no hedge funds are holding shares in DE:M3L
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Modern Healthcare Technology Holdings Limited
Modern Healthcare Technology Holdings Limited, an investment holding company, provides beauty and wellness services in Hong Kong, the People's Republic of China, Singapore, and Australia. The company operates in two segments, Beauty and Wellness Services, and Skincare and Wellness Products. It offers beauty and facial services; aesthetics services, such as skincare treatment, professional consultation, skin care and anti-ageing, and referral services on plastic reconstruction; slimming services, including weight management programs; and spa and massage services comprising resplendent bathroom furnishings and a hydrotherapeutic pool, as well as foot spa, foot treatment, and foot massage services. The company also sells skincare and wellness products under the be, FERRECARE, p.e.n, Y.U.E., Advanced Natural, Malu Wilz, Byotea, Care Plus, Cellnoc, Mu-lan Spa, Cellnoc, Veribe, Castille, Dr Plus, Eclat du teint, and Natural Care brand names. In addition, it provides franchise and trademark services in relation to beautification and gymnastic services; advertising services; maid agency services; and management services, as well as food and beverage services. As of March 31, 2022, the company had 30 service centers in Hong Kong; 3 service centers in Mainland China; and 7 service centers in Singapore, as well as 8 be Beauty Shop outlets. Modern Healthcare Technology Holdings Limited is headquartered in Kowloon Bay, Hong Kong.
Anxian Yuan China Holdings Limited
―
Miricor Enterprises Holdings Ltd
―
China Wan Tong Yuan (Holdings) Ltd.
―
Sino-Life Group Limited
―
Fameglow Holdings Limited
―